🇺🇸
United States · US · US:0023-6498_07fd3ef4-ef45-4b86-a6ab-75457fbe68ca
UBRELVY
Orange BookUNIISPLATC N02CD04
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerAllergan, Inc.
CountryUS (United States)
ATC codeN02CD04
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 0
No packs registered.
Annotations
UNII (FDA Substance ID)
AD0O8X2QJR
UBROGEPANT
RxCUI 2268216
Orange Book
N211765
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "AD0O8X2QJR",
"rxcui": "2268216",
"inchikey": "DDOOFTLHJSMHLN-ZQHRPCGSSA-N",
"display_name": "UBROGEPANT",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"fd9f9458-fd96-4688-be3f-f77b3d1af6ab": {
"match": "brand_token",
"title": "UBRELVY (UBROGEPANT) TABLET [ALLERGAN, INC.]",
"spl_version": "27",
"published_date": "2025-06-18"
}
},
"productid": "0023-6498_07fd3ef4-ef45-4b86-a6ab-75457fbe68ca",
"productndc": "0023-6498",
"dosage_form": "TABLET",
"orange_book": {
"appl_no": "211765",
"products": [
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "50MG",
"product_no": "001",
"approval_date": "Dec 23, 2019"
},
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "100MG",
"product_no": "002",
"approval_date": "Dec 23, 2019"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "UBROGEPANT",
"proprietary_name": "UBRELVY",
"active_ingred_unit": "mg/1",
"application_number": "NDA211765",
"marketing_category": "NDA",
"nonproprietary_name": "ubrogepant",
"start_marketing_date": "20191223",
"active_numerator_strength": "50"
}Related drugs
Other records sharing ATC code N02CD04.
Access this data programmatically
Query UBRELVY and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.